Malin Wennström

Malin Wennström


Personal profile


Our goal is to identify new early mechanisms and biomarkers associated with Alzheimer’s disease (AD), and thereby improve the development of new treatments and diagnostic tools.  We have therefore, over the years, together with national and international colleagues and collaborators, investigated the impact of AD risk factors (such as stress, inflammation, metabolic changes and amyloidogenesis) on different types of brain cells. Our scientific approach is to use translational studies primarily conducted on human samples (brain, retina, CSF and cells isolated from postmortem adult and fetal brain). By the use of such studies, we have revealed several new mechanisms and biomarkers associated with AD, including alteration of glycogen metabolism, toxicity/specificity of varios amyloid peptides and secretion of various pathology-specific molecules.  

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

UKÄ subject classification

  • Medical and Health Sciences
  • Neurosciences

Free keywords

  • Alzheimers disease, pericytes, neuroinflammation, a stress, amyloid peptides, amyloid beta, amylin, glycogen, Amylase


Dive into the research topics where Malin Wennström is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or